As COVID wreaked havoc on our markets, biotech appeared to be an outlier, not just weathering the storm, but emerging stronger than ever with record investments and valuations. Then reality struck. Assets lingered in early stages. Commercialized products underperformed. Valuations tumbled….
Source: news.google.com – Read more
Two Windows vulnerabilities, one a 0-day, are under active exploitation
Two Windows vulnerabilities—one a zero-day that has been known to attackers since 2017 and the other a critical flaw that Microsoft initially tried and failed
